CoChat

A Biomimetic Microfluidic Tumor Microenvironment Platform Mimicking the EPR Effect for Rapid Screening of Drug Delivery Systems

Open access

The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.

Abstract

Real-time monitoring of tumor drug delivery in vivo is a daunting challenge due to the heterogeneity and complexity of the tumor microenvironment. In this study, we developed a biomimetic microfluidic tumor microenvironment (bMTM) comprising co-culture of tumor and endothelial cells in a 3D environment. The platform consists of a vascular compartment featuring a network of vessels cultured with endothelial cells forming a complete lumen under shear flow in communication with 3D solid tumors cultured in a tumor compartment. Endothelial cell permeability to both small dye molecules and large liposomal drug carriers were quantified using fluorescence microscopy. Endothelial cell intercellular junction formation was characterized by immunostaining. Endothelial cell permeability significantly increased in the presence of either tumor cell conditioned media (TCM) or tumor cells. The magnitude of this increase in permeability was significantly higher in the presence of metastatic breast tumor cells as compared to non-metastatic ones. Immunostaining revealed impaired endothelial cell-cell junctions in the presence of either metastatic TCM or metastatic tumor cells. Our findings indicate that the bMTM platform mimics the tumor microenvironment including the EPR effect. This platform has a significant potential in applications such as cell-cell/cell-drug carrier interaction studies and rapid screening of cancer drug therapeutics/carriers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-09815-9

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic of the bMTM (A) with magnified view of the vascular compartment, vascular-tumor compartment interface and the tumor compartment (B). Optical image of the bMTM (C) with HBTAEC cultured in the vascular compartment (D) and MDA-MB-231 cultured in the tumor compartment (E). HBTAEC cultured under flow in the vascular compartment of bMTM form a complete lumen as shown with 3D reconstruction of confocal images of HBTAEC cultured in bMTM stained with f-actin (green) and Draq5 (red) after 4 days in culture maintained under flow of 0.05 μl/min (F–I); images are shown with a Y-axis rotation of 0, 60, 180 and 240 degrees in (F,G,H and I) respectively.
Figure 1 Schematic of the bMTM (A) with magnified view of the vascular compartment, vascular-tumor compartment interface and the tumor compartment (B). Optical image of the bMTM (C) with HBTAEC cultured in the vascular compartment (D) and MDA-MB-231 cultured in the tumor compartment (E). HBTAEC cultured under flow in the vascular compartment of bMTM form a complete lumen as shown with 3D reconstruction of confocal images of HBTAEC cultured in bMTM stained with f-actin (green) and Draq5 (red) after 4 days in culture maintained under flow of 0.05 μl/min (F–I); images are shown with a Y-axis rotation of 0, 60, 180 and 240 degrees in (F,G,H and I) respectively.CC BY · PubMed Central
Figure 2 Culturing tumor endothelial cell (HBTAEC) in the vascular compartment for 48 h significantly decreased permeability compared to bMTM with no cells. Permeability of the fluorescent 40 kD dextran from vascular compartment to the tumor compartment in a cell-free bMTM were quantified by normalizing the fluorescent intensity in the tumor to the vascular compartment while fluorescent dextrans diffuse from the vascular compartment to the tumor compartment (panel A). Permeability increased when endothelial cells were treated with TNF-α but was still significantly lower than in cell-free bMTM (panel B). Data are presented as mean ± SEM (n = 3). *Significant difference by ANOVA.
Figure 2 Culturing tumor endothelial cell (HBTAEC) in the vascular compartment for 48 h significantly decreased permeability compared to bMTM with no cells. Permeability of the fluorescent 40 kD dextran from vascular compartment to the tumor compartment in a cell-free bMTM were quantified by normalizing the fluorescent intensity in the tumor to the vascular compartment while fluorescent dextrans diffuse from the vascular compartment to the tumor compartment (panel A). Permeability increased when endothelial cells were treated with TNF-α but was still significantly lower than in cell-free bMTM (panel B). Data are presented as mean ± SEM (n = 3). *Significant difference by ANOVA.CC BY · PubMed Central
Figure 3 Tumor conditioned media (TCM) (48 h treatment) from highly metastatic MDA-MB-231 tumor cells significantly increased HBTAEC permeability to 40 kD Texas Red dextran compared to treatment with TCM from less metastatic MCF-7 tumor cells or when cultured with normal media. Data are presented as mean ± SEM (n = 3). *Significant difference by ANOVA.
Figure 3 Tumor conditioned media (TCM) (48 h treatment) from highly metastatic MDA-MB-231 tumor cells significantly increased HBTAEC permeability to 40 kD Texas Red dextran compared to treatment with TCM from less metastatic MCF-7 tumor cells or when cultured with normal media. Data are presented as mean ± SEM (n = 3). *Significant difference by ANOVA.CC BY · PubMed Central
Figure 4 Permeability of HBTAEC increased significantly with increasing co-culture duration with highly metastatic MDA-MB-231 cells (panel A) and was accompanied by morphological changes in endothelial cells (panels B–D). HBTAEC cultured without tumor cells showed no change in morphology for 120 h (panel B) but endothelial cell morphology changed significantly when co-cultured with MDA-MB-231 cells for 120 h (panel C). HBTAEC co-cultured with MCF-7 cells for 120 h showed fewer morphological changes (panel D). Data are presented as mean ± SEM (n = 3). *Significant difference by two-way ANOVA.
Figure 4 Permeability of HBTAEC increased significantly with increasing co-culture duration with highly metastatic MDA-MB-231 cells (panel A) and was accompanied by morphological changes in endothelial cells (panels B–D). HBTAEC cultured without tumor cells showed no change in morphology for 120 h (panel B) but endothelial cell morphology changed significantly when co-cultured with MDA-MB-231 cells for 120 h (panel C). HBTAEC co-cultured with MCF-7 cells for 120 h showed fewer morphological changes (panel D). Data are presented as mean ± SEM (n = 3). *Significant difference by two-way ANOVA.CC BY · PubMed Central
Figure 5 Tumor conditioned media (TCM) (48 h treatment) from highly metastatic MDA-MB-231 tumor cells increased liposome extravasation into the tumor compartment as indicated by the ratio of fluorescent liposome intensity in the tumor compartment to the vascular compartment (panel A). Liposomes extravasated more after MDA-MB-231 conditioned media or TNF-α treatment, but were not affected by TCM obtained from non-metastatic MCF-7 tumor cells (panels B–E). Data are presented as mean ± SEM (n = 3). *Significant difference by ANOVA.
Figure 5 Tumor conditioned media (TCM) (48 h treatment) from highly metastatic MDA-MB-231 tumor cells increased liposome extravasation into the tumor compartment as indicated by the ratio of fluorescent liposome intensity in the tumor compartment to the vascular compartment (panel A). Liposomes extravasated more after MDA-MB-231 conditioned media or TNF-α treatment, but were not affected by TCM obtained from non-metastatic MCF-7 tumor cells (panels B–E). Data are presented as mean ± SEM (n = 3). *Significant difference by ANOVA.CC BY · PubMed Central
Figure 6 The changes in HBTAEC permeability when co-cultured with tumor cells shown in Fig. 4, resulted in enhanced liposome extravasation with increasing co-culture duration. Data are presented as mean ± SEM (n = 3). *Significant difference by ANOVA.
Figure 6 The changes in HBTAEC permeability when co-cultured with tumor cells shown in Fig. 4, resulted in enhanced liposome extravasation with increasing co-culture duration. Data are presented as mean ± SEM (n = 3). *Significant difference by ANOVA.CC BY · PubMed Central
Figure 7 Different formulations of liposomes have different levels of adhesion and extravasation after 48 h of co-culture of HBTAEC and MDA-MB-231 tumor cells. Functionalized liposomes with antibodies to E-selectin (a-E-selectin) have significantly higher adhesion in the vascular compartment and extravasation into the tumor compartment (Figure S3). Dual targeting to both E-selectin and ICAM-1further increased binding when compared to E-selectin single targeting (positive control, Figure S3). Extravasation of E-selectin targeted liposomes was significantly increased when compared to non-targeted liposomes, but no significant difference in extravasation was observed between single and dual targeted liposomes. Data are presented as mean ± SEM (n = 3). *Significant difference by ANOVA.
Figure 7 Different formulations of liposomes have different levels of adhesion and extravasation after 48 h of co-culture of HBTAEC and MDA-MB-231 tumor cells. Functionalized liposomes with antibodies to E-selectin (a-E-selectin) have significantly higher adhesion in the vascular compartment and extravasation into the tumor compartment (Figure S3). Dual targeting to both E-selectin and ICAM-1further increased binding when compared to E-selectin single targeting (positive control, Figure S3). Extravasation of E-selectin targeted liposomes was significantly increased when compared to non-targeted liposomes, but no significant difference in extravasation was observed between single and dual targeted liposomes. Data are presented as mean ± SEM (n = 3). *Significant difference by ANOVA.CC BY · PubMed Central
Figure 8 HBTAEC lumen formation as indicated by VE-cadherin (red) is shear flow dependent. Cell nucleus were stained with Hoechst 33342 (blue). At low shear regions (white arrows), the red staining were intermittent indicating less VE-cadherin formation (panel A). When co-cultured with highly metastatic MDA-MB-231 tumor cells, VE-cadherin expression in HBTEAC were inhibted (panel B). The presence of less metastatic MCF-7 tumor cells did not change the formation of adherens junctions (panel C).
Figure 8 HBTAEC lumen formation as indicated by VE-cadherin (red) is shear flow dependent. Cell nucleus were stained with Hoechst 33342 (blue). At low shear regions (white arrows), the red staining were intermittent indicating less VE-cadherin formation (panel A). When co-cultured with highly metastatic MDA-MB-231 tumor cells, VE-cadherin expression in HBTEAC were inhibted (panel B). The presence of less metastatic MCF-7 tumor cells did not change the formation of adherens junctions (panel C).CC BY · PubMed Central
Figure 9 Highly metastatic MDA-MB-231 tumor cells reduced endothelial cell adherens junction (VE-cadherin) molecule expression. When cultured without the presence of tumor cells, adherens junctions were fully established between adjacent cells. When co-cultured with MDA-MB-231 tumor cells, VE-cadherin was partially expressed between adjacent cells, while no change in VE-cadherin expression was observed when HBTAEC were co-cultured with MCF-7 tumor cells. Cell adherens junction molecule was stained with VE-cadherein antibody (red); cell F-actin microfilament was stained with phalloidin (green); cell nucleus was counterstained with Hoechst 33342 (blue).
Figure 9 Highly metastatic MDA-MB-231 tumor cells reduced endothelial cell adherens junction (VE-cadherin) molecule expression. When cultured without the presence of tumor cells, adherens junctions were fully established between adjacent cells. When co-cultured with MDA-MB-231 tumor cells, VE-cadherin was partially expressed between adjacent cells, while no change in VE-cadherin expression was observed when HBTAEC were co-cultured with MCF-7 tumor cells. Cell adherens junction molecule was stained with VE-cadherein antibody (red); cell F-actin microfilament was stained with phalloidin (green); cell nucleus was counterstained with Hoechst 33342 (blue).CC BY · PubMed Central
Figure 10 Highly metastatic MDA-MB-231 tumor cells reduced endothelial cell tight junction (ZO-1) molecule expression. When cultured without tumor cells, tight junctions were fully established between adjacent cells. When co-cultured with MDA-MB-231 tumor cells, tight junctions were intermittently expressed along the edge of contacting endothelial cells, while no change was observed when HBTAEC were co-cultured with MCF-7 tumor cells. Cell tight junction molecule was stained with ZO-1 antibody (red); cell F-actin microfilament was stained with phalloidin (green); cell nucleus was counterstained with Hoechst 33342 (blue).
Figure 10 Highly metastatic MDA-MB-231 tumor cells reduced endothelial cell tight junction (ZO-1) molecule expression. When cultured without tumor cells, tight junctions were fully established between adjacent cells. When co-cultured with MDA-MB-231 tumor cells, tight junctions were intermittently expressed along the edge of contacting endothelial cells, while no change was observed when HBTAEC were co-cultured with MCF-7 tumor cells. Cell tight junction molecule was stained with ZO-1 antibody (red); cell F-actin microfilament was stained with phalloidin (green); cell nucleus was counterstained with Hoechst 33342 (blue).CC BY · PubMed Central
Figure 11 Permeability values obtained in the bMTM with or without tumor cells (in red) are similar to reported in vivo values. Experimental results obtained using the bMTM platform (range and median) are highlighted in red and represent permeability of HBTAEC when cultured without tumor cells (A), co-cultured with MCF-7 (B), or co-cultured with MDA-MB-231 (C). The references for each set of in vivo data are given in parenthesis.
Figure 11 Permeability values obtained in the bMTM with or without tumor cells (in red) are similar to reported in vivo values. Experimental results obtained using the bMTM platform (range and median) are highlighted in red and represent permeability of HBTAEC when cultured without tumor cells (A), co-cultured with MCF-7 (B), or co-cultured with MDA-MB-231 (C). The references for each set of in vivo data are given in parenthesis.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 69 references

Research works printed but not linked: 1

  1. Hashizume, H. et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 156, 1363–1380, doi:10.1016/S0002-9440(10)65006-7 (2000). · DOI · Paper page

Cited by

See all 109

Metadata

Authors
Tang, Y., Soroush, F., Sheffield, J. B., Wang, B., Prabhakarpandian, B., & Kiani, M. F.
Affiliations
  • Temple University (US)
  • Widener University (US)
  • CFD Research Corporation (United States) (US)
Corresponding author
Kiani, Mohammad F.
Venue
Scientific Reports
Published
2017-08-24
Volume
7
Issue
1
Pages
9359-9359
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2747317315
Cited by
102
References
69
Citations by year
2026: 1 · 2025: 3 · 2024: 9 · 2023: 6 · 2022: 17 · 2021: 17 · 2020: 11 · 2019: 18 · 2018: 18 · 2017: 2
FWCI
6.03
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • TUScholarShare (Temple University) (submittedVersion, cc-by)
Funders
  • American Heart Association
  • National Institutes of Health
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords
enhanced permeability and retention effect, endothelial permeability, tumor microenvironment, metastatic breast cancer, liposomal drug carriers, tumor vasculature
MeSH terms
Cell Communication, Cell Movement, Drug Carriers, Fluorescent Antibody Technique, Humans, Intercellular Junctions, Liposomes, Neoplasm Metastasis, Neoplasms, Permeability, Drug Delivery Systems, Coculture Techniques, Biomimetics, Endothelial Cells, Microfluidics, Cell Line, Tumor, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Biomimetic Microfluidic Tumor Microenvironment Platform Mimicking the EPR Effect for Rapid Screening of Drug Delivery Systems. https://app.cochat.ai/papers/10.1038/s41598-017-09815-9
The paper
Tang, Y., Soroush, F., Sheffield, J. B., Wang, B., Prabhakarpandian, B., & Kiani, M. F. (2017). A Biomimetic Microfluidic Tumor Microenvironment Platform Mimicking the EPR Effect for Rapid Screening of Drug Delivery Systems. Scientific Reports. https://doi.org/10.1038/s41598-017-09815-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.